 |
 |

The Effect of BCG Vaccination on Tuberculin Reactivity and the Booster Effect Among Hospital Employees
Santiago Moreno, MD;
Rosa Blázquez, MD;
Abel Novoa, MD;
Isabel Carpena, MD;
Ana Menasalvas, MD;
Cristóbal Ramírez, PharmD;
Carmen Guerrero, MD
Arch Intern Med. 2001;161:1760-1765.
Background We estimated the effect of remote BCG vaccination on tuberculin reactivity
and the booster effect among hospital employees.
Methods Cross-sectional survey at a university hospital. All personnel employed
during a 24-month period were included in the study. Employees were administered
2-step tuberculin testing, and BCG vaccination scars were verified.
Results Of 665 hospital employees studied, 239 (36%) had been vaccinated with
BCG in childhood. Significant tuberculin reactions ( 5 mm) were more frequent
among BCG-vaccinated (60%) than among nonvaccinated (29%) employees (odds
ratio [OR], 3.6; 95% confidence interval [CI], 2.6-5.2). The predictive value
of tuberculosis infection increased with increasing reaction size and greater
age (from 37% in subjects 30 years or younger with indurations 5 mm to
100% in subjects 50 years or older with indurations 15 mm). Among 374
employees with a negative tuberculin test reaction who underwent a second
test, 39 (43%) of 91 vaccinated subjects had a positive booster reaction in
contrast to 51 (22%) of 232 nonvaccinated subjects (OR, 3.4; 95% CI, 2-5.7).
Neither different size criteria nor different definitions of the booster effect
had an impact on the predictive value of tuberculosis infection.
Conclusions Remote BCG vaccination largely influences the tuberculin reaction and
the boosting phenomenon among hospital employees. The interpretation of the
results of 2-step tuberculin testing in a BCG-vaccinated subject must take
into account age, size of the reaction, and local prevalence of tuberculosis
infection. No single criterion, however, can accurately separate reactions
caused by true infection from those caused by BCG vaccination.
From the Department of Clinical Microbiology and Infectious Diseases,
Hospital General Universitario José Ma Morales Meseguer,
Murcia, Spain. Dr Moreno is now with the Department of Infectious Diseases,
Hospital Ramón Cajal, Madrid, Spain.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Risk of tuberculin conversion among healthcare workers and the adoption of preventive measures
Baussano et al.
Occup. Environ. Med. 2007;64:161-166.
ABSTRACT
| FULL TEXT
|